153 related articles for article (PubMed ID: 11766740)
21. [An ovarian mucinous borderline tumour with mixed mural nodules].
Dhouibi A; Denoux Y; Touil N; Devouassoux Shisheboran M; Carbonnel M; Baglin AC
J Gynecol Obstet Biol Reprod (Paris); 2011 Sep; 40(5):469-72. PubMed ID: 21531088
[TBL] [Abstract][Full Text] [Related]
22. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
[TBL] [Abstract][Full Text] [Related]
23. The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor.
Seckin KD; Karslı MF; Yucel B; Bestel M; Yıldırım D; Canaz E; Akbayır O
Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():60-3. PubMed ID: 26683535
[TBL] [Abstract][Full Text] [Related]
24. Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality.
Khunamornpong S; Suprasert P; Pojchamarnwiputh S; Na Chiangmai W; Settakorn J; Siriaunkgul S
Gynecol Oncol; 2006 Apr; 101(1):152-7. PubMed ID: 16300822
[TBL] [Abstract][Full Text] [Related]
25. k-ras mutation may be an early event in mucinous ovarian tumorigenesis.
Garrett AP; Lee KR; Colitti CR; Muto MG; Berkowitz RS; Mok SC
Int J Gynecol Pathol; 2001 Jul; 20(3):244-51. PubMed ID: 11444200
[TBL] [Abstract][Full Text] [Related]
26. The pathologic distinction of primary and metastatic mucinous tumors involving the ovary: A re-evaluation of algorithms based on gross features.
Hu J; Khalifa RD; Roma AA; Fadare O
Ann Diagn Pathol; 2018 Dec; 37():1-6. PubMed ID: 30179792
[TBL] [Abstract][Full Text] [Related]
27. Serum CA19-9 as a predictor of malignancy in primary ovarian mucinous tumors: a matched case-control study.
Cho HY; Kyung MS
Med Sci Monit; 2014 Jul; 20():1334-9. PubMed ID: 25073801
[TBL] [Abstract][Full Text] [Related]
28. Pathology of primary and metastatic mucinous ovarian neoplasms.
Leen SL; Singh N
J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188
[TBL] [Abstract][Full Text] [Related]
29. Borderline epithelial tumors of the ovary.
Hart WR
Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
[TBL] [Abstract][Full Text] [Related]
30. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases.
Nomura K; Aizawa S
Cancer; 2000 Oct; 89(7):1541-6. PubMed ID: 11013369
[TBL] [Abstract][Full Text] [Related]
32. Clinical and ultrasound features of benign, borderline, and malignant invasive mucinous ovarian tumors.
Pascual A; Guerriero S; Rams N; Juez L; Ajossa S; Graupera B; Hereter L; Cappai A; Pero M; Perniciano M; Errasti T; Parra J; Solis M; Alcázar JL
Eur J Gynaecol Oncol; 2017; 38(3):382-386. PubMed ID: 29693878
[TBL] [Abstract][Full Text] [Related]
33. Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary.
Ronnett BM; Shmookler BM; Sugarbaker PH; Kurman RJ
Anat Pathol; 1997; 2():197-226. PubMed ID: 9575376
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Discordance in Intraoperative Frozen Section Diagnosis of Ovarian Tumors: A Literature Review and Analysis of 871 Cases Treated at a Japanese Cancer Center.
Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2021 Feb; 29(1):30-38. PubMed ID: 32955372
[TBL] [Abstract][Full Text] [Related]
35. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
[TBL] [Abstract][Full Text] [Related]
36. Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors.
Dolivet E; Gaichies L; Jeanne C; Bazille C; Briand M; Vernon M; Giffard F; Leprêtre F; Poulain L; Denoyelle C; Vigneron N; Fauvet R
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958997
[TBL] [Abstract][Full Text] [Related]
37. Primary mixed neuroendocrine and mucinous carcinoma of the ovary.
Collins RJ; Cheung A; Ngan HY; Wong LC; Chan SY; Ma HK
Arch Gynecol Obstet; 1991; 248(3):139-43. PubMed ID: 1850226
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
Jordan SJ; Green AC; Whiteman DC; Webb PM;
Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: a report of 16 cases.
Khunamornpong S; Lerwill MF; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Chiangmai WN; Young RH
Int J Gynecol Pathol; 2008 Jul; 27(3):366-79. PubMed ID: 18580314
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of frozen section diagnosis in borderline ovarian malignancy.
Kayikçioglu F; Pata O; Cengiz S; Tulunay G; Boran N; Yalvaç S; Köse MF
Gynecol Obstet Invest; 2000; 49(3):187-9. PubMed ID: 10729760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
